194 related articles for article (PubMed ID: 36775962)
21. Hypoxia-inducible KDM3A addiction in multiple myeloma.
Ikeda S; Kitadate A; Abe F; Takahashi N; Tagawa H
Blood Adv; 2018 Feb; 2(4):323-334. PubMed ID: 29444873
[TBL] [Abstract][Full Text] [Related]
22. Nrf2-AKT interactions regulate heme oxygenase 1 expression in kidney epithelia during hypoxia and hypoxia-reoxygenation.
Potteti HR; Tamatam CR; Marreddy R; Reddy NM; Noel S; Rabb H; Reddy SP
Am J Physiol Renal Physiol; 2016 Nov; 311(5):F1025-F1034. PubMed ID: 27582105
[TBL] [Abstract][Full Text] [Related]
23. Shikonin and cisplatin synergistically overcome cisplatin resistance of ovarian cancer by inducing ferroptosis via upregulation of HMOX1 to promote Fe
Ni M; Zhou J; Zhu Z; Xu Q; Yin Z; Wang Y; Zheng Z; Zhao H
Phytomedicine; 2023 Apr; 112():154701. PubMed ID: 36773431
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial thioredoxin reductase regulates major cytotoxicity pathways of proteasome inhibitors in multiple myeloma cells.
Fink EE; Mannava S; Bagati A; Bianchi-Smiraglia A; Nair JR; Moparthy K; Lipchick BC; Drokov M; Utley A; Ross J; Mendeleeva LP; Savchenko VG; Lee KP; Nikiforov MA
Leukemia; 2016 Jan; 30(1):104-11. PubMed ID: 26205085
[TBL] [Abstract][Full Text] [Related]
25. MAPK/JNK1 activation protects cells against cadmium-induced autophagic cell death via differential regulation of catalase and heme oxygenase-1 in oral cancer cells.
So KY; Kim SH; Jung KT; Lee HY; Oh SH
Toxicol Appl Pharmacol; 2017 Oct; 332():81-91. PubMed ID: 28782507
[TBL] [Abstract][Full Text] [Related]
26. Indirubin-3'-monoxime acts as proteasome inhibitor: Therapeutic application in multiple myeloma.
Yu Z; Wei X; Liu L; Sun H; Fang T; Wang L; Li Y; Sui W; Wang K; He Y; Zhao Y; Huang W; An G; Meng F; Huang C; Yu T; Anderson KC; Cheng T; Qiu L; Hao M
EBioMedicine; 2022 Apr; 78():103950. PubMed ID: 35344764
[TBL] [Abstract][Full Text] [Related]
27. Resveratrol exhibits neuroprotection against paraquat-induced PC12 cells via heme oxygenase 1 upregulation by decreasing MiR-136-5p expression.
Zhang L; Dong MN; Deng J; Zhang CH; Liu MW
Bioengineered; 2022 Mar; 13(3):7065-7081. PubMed ID: 35236239
[TBL] [Abstract][Full Text] [Related]
28. Exercise-induced oxidative stress and hypoxic exercise recovery.
Ballmann C; McGinnis G; Peters B; Slivka D; Cuddy J; Hailes W; Dumke C; Ruby B; Quindry J
Eur J Appl Physiol; 2014 Apr; 114(4):725-33. PubMed ID: 24384982
[TBL] [Abstract][Full Text] [Related]
29. Hypoxia-inducible microRNA-210 regulates the DIMT1-IRF4 oncogenic axis in multiple myeloma.
Ikeda S; Kitadate A; Abe F; Saitoh H; Michishita Y; Hatano Y; Kawabata Y; Kitabayashi A; Teshima K; Kume M; Takahashi N; Tagawa H
Cancer Sci; 2017 Apr; 108(4):641-652. PubMed ID: 28164410
[TBL] [Abstract][Full Text] [Related]
30. Resensitising proteasome inhibitor-resistant myeloma with sphingosine kinase 2 inhibition.
Bennett MK; Li M; Tea MN; Pitman MR; Toubia J; Wang PP; Anderson D; Creek DJ; Orlowski RZ; Gliddon BL; Powell JA; Wallington-Beddoe CT; Pitson SM
Neoplasia; 2022 Jan; 24(1):1-11. PubMed ID: 34826777
[TBL] [Abstract][Full Text] [Related]
31. Targeted knockdown of DJ-1 induces multiple myeloma cell death via KLF6 upregulation.
Raninga PV; Di Trapani G; Vuckovic S; Tonissen KF
Apoptosis; 2016 Dec; 21(12):1422-1437. PubMed ID: 27734217
[TBL] [Abstract][Full Text] [Related]
32. Dysregulation of hypoxia-inducible factor-1α (Hif1α) expression in the Hmox1-deficient placenta.
Zhao H; Narasimhan P; Kalish F; Wong RJ; Stevenson DK
Placenta; 2020 Sep; 99():108-116. PubMed ID: 32784053
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of the ʟ-glutamine transporter ASCT2 sensitizes plasma cell myeloma cells to proteasome inhibitors.
Prelowska MK; Mehlich D; Ugurlu MT; Kedzierska H; Cwiek A; Kosnik A; Kaminska K; Marusiak AA; Nowis D
Cancer Lett; 2021 Jun; 507():13-25. PubMed ID: 33713737
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of heme oxygenase-1 in bone marrow stromal cells promotes multiple myeloma resistance through the JAK2/STAT3 pathway.
Huang J; Huang LQ; He HS; Yan J; Huang C; Wang R; Guan Y; Huang DP
Life Sci; 2020 Sep; 257():118088. PubMed ID: 32663573
[TBL] [Abstract][Full Text] [Related]
35. Proteasome inhibition and oxidative reactions disrupt cellular homeostasis during heme stress.
Vallelian F; Deuel JW; Opitz L; Schaer CA; Puglia M; Lönn M; Engelsberger W; Schauer S; Karnaukhova E; Spahn DR; Stocker R; Buehler PW; Schaer DJ
Cell Death Differ; 2015 Apr; 22(4):597-611. PubMed ID: 25301065
[TBL] [Abstract][Full Text] [Related]
36. [Identification of hypoxia-specific therapeutic targets in multiple myeloma].
Ikeda S
Rinsho Ketsueki; 2021; 62(4):305-313. PubMed ID: 33967156
[TBL] [Abstract][Full Text] [Related]
37. Proteasome inhibitor induced SIRT1 deacetylates GLI2 to enhance hedgehog signaling activity and drug resistance in multiple myeloma.
Xie Y; Liu J; Jiang H; Wang J; Li X; Wang J; Zhu S; Guo J; Li T; Zhong Y; Zhang Q; Liu Z
Oncogene; 2020 Jan; 39(4):922-934. PubMed ID: 31576013
[TBL] [Abstract][Full Text] [Related]
38. CCR10/CCL27 crosstalk contributes to failure of proteasome-inhibitors in multiple myeloma.
Thangavadivel S; Zelle-Rieser C; Olivier A; Postert B; Untergasser G; Kern J; Brunner A; Gunsilius E; Biedermann R; Hajek R; Pour L; Willenbacher W; Greil R; Jöhrer K
Oncotarget; 2016 Nov; 7(48):78605-78618. PubMed ID: 27732933
[TBL] [Abstract][Full Text] [Related]
39. Nrf2/HO-1 pathway activation by manganese is associated with reactive oxygen species and ubiquitin-proteasome pathway, not MAPKs signaling.
Li H; Wu S; Shi N; Lian S; Lin W
J Appl Toxicol; 2011 Oct; 31(7):690-7. PubMed ID: 21384399
[TBL] [Abstract][Full Text] [Related]
40. Andrographolide inhibits hypoxia-induced HIF-1α-driven endothelin 1 secretion by activating Nrf2/HO-1 and promoting the expression of prolyl hydroxylases 2/3 in human endothelial cells.
Lin HC; Su SL; Lu CY; Lin AH; Lin WC; Liu CS; Yang YC; Wang HM; Lii CK; Chen HW
Environ Toxicol; 2017 Mar; 32(3):918-930. PubMed ID: 27297870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
